Now showing items 1-3 of 3

    • Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma. 

      Siskos, AP; Jain, P; Römisch-Margl, W; Bennett, M; Achaintre, D; Asad, Y; Marney, L; Richardson, L; Koulman, A; Griffin, JL; Raynaud, F; Scalbert, A; Adamski, J; Prehn, C; Keun, HC (2017-01)
      A critical question facing the field of metabolomics is whether data obtained from different centers can be effectively compared and combined. An important aspect of this is the interlaboratory precision (reproducibility) ...
    • Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work. 

      Robinson, M; James, J; Thomas, G; West, N; Jones, L; Lee, J; Oien, K; Freeman, A; Craig, C; Sloan, P; Elliot, P; Cheang, M; Rodriguez-Justo, M; Verrill, C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group (2019-04)
      While pathologists have always played a pivotal role in clinical trials ensuring accurate diagnosis and staging, pathology data from prognostic and predictive tests are increasingly being used to enrol, stratify and randomise ...
    • Training and accreditation standards for pathologists undertaking clinical trial work. 

      Rees, G; Salto-Tellez, M; Lee, JL; Oien, K; Verrill, C; Freeman, A; Mirabile, I; West, NP; National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group (2019-04)
      Clinical trials rely on multidisciplinary teams for successful delivery. Pathologists should be involved in clinical trial design from the outset to ensure that protocols are optimised to deliver maximum data collection ...